EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Pregnancy outcomes following oral brivudine exposure: two case studies with long-term follow-up

Nusret Uysal, Ismail Yilmaz, Baris Karadas, Nihal Olgac Dundar, Yusuf Cem Kaplan

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-05 · 399 (8) · 12771-12773

DOI: 10.1007/s00210-026-05154-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 04.03.2026. Verfasst von Nusret Uysal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Marmara University School of Medicine, Istanbul, Turkey. nusret.uysal@marmara.edu.tr. Hauptthemen laut MEDLINE: Abnormalities, Drug-Induced, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marmara University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brivudine is a thymidine analogue antiviral agent used in the treatment of herpes zoster; however, human data regarding its use during pregnancy are lacking. This report aims to describe pregnancy outcomes following oral brivudine exposure and to provide the first human clinical data on brivudine use during pregnancy. Two pregnant women exposed to oral brivudine during the first and second trimesters were referred for teratological risk assessment and followed with perinatal monitoring and postnatal clinical follow-up. Both pregnancies were continued with perinatological follow-up and resulted in the delivery of healthy infants without major congenital malformations. Postnatal follow-up identified mild allergic manifestations in one child and an isolated mild delay in the personal–social developmental domain in the other. These cases provide preliminary clinical data on brivudine exposure during pregnancy and contribute to the limited human data available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abnormalities, Drug-InducedAntiviral AgentsAdultFemaleHumansInfant, NewbornPregnancyAdministration, OralFollow-Up StudiesPregnancy OutcomeYoung Adult

Stichwörter der Autor:innen

BrivudineCongenital abnormalitiesPregnancyTeratology

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Medical Pharmacology, Marmara University School of Medicine, Istanbul, Turkey. nusret.uysal@marmara.edu.tr.
  • TERAFAR (Izmir Kâtip Celebi University Teratology Information, Training and Research Center), Izmir, Turkey.
  • Department of Pediatrics, Division of Pediatric Neurology, Izmir Kâtip Celebi University, Izmir, Turkey.

Förderung

  • Marmara University

Zitieren

APA

Uysal, N., Yilmaz, I., Karadas, B., Dundar, N. O., & Kaplan, Y. C. (2026). Pregnancy outcomes following oral brivudine exposure: two case studies with long-term follow-up. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(8), 12771-12773. https://doi.org/10.1007/s00210-026-05154-7

Vancouver

Uysal N, Yilmaz I, Karadas B, Dundar NO, Kaplan YC. Pregnancy outcomes following oral brivudine exposure: two case studies with long-term follow-up. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(8):12771-12773. doi:10.1007/s00210-026-05154-7

BibTeX
@article{Uysal2026,
  author = {Uysal, Nusret and Yilmaz, Ismail and Karadas, Baris and Dundar, Nihal Olgac and Kaplan, Yusuf Cem},
  title = {Pregnancy outcomes following oral brivudine exposure: two case studies with long-term follow-up},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {8},
  pages = {12771--12773},
  doi = {10.1007/s00210-026-05154-7}
}
Kostenlos starten →